Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?



Rating:

Share or cite this content

Citations should be made in the following way:
C. Thomson (Boston, United States of America). Screening for lung cancer: who should (not) be enrolled?. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?

Member's Comments

No comment yet.

Related content which might interest you: Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Is the lung cancer in elderly similar to lung cancer in younger patients? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening? Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018 Year: 2018 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Active TB in cancer patients: A missed screening opportunity? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Panel discussion: Improving the pathway of lung cancer patients, can we do it better? Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better? Year: 2021 Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)] Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Screening and follow up of occult lung carcinoma (Tx) in a smoker population Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003 Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Follow up of surgically treated non small cell lung cancer patients: which modalities? Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008 KBP-2010-CPHG: Characteristics and management of 6,083 new cases of non-small-cell-lung-cancer (NSCLC) Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Small cell lung cancer (SCLC) in Norway. A population-based study Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 European treatment guidelines: small cell lung cancer (SCLC) Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009